SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

CUSIP: 78397T202

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+9,033,343
SEC-reported price per share
$3.17
Indexed holders
71
Value change
+$28,604,361
Number of buys
42
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
95,713,930

Security key

78397T202

Report period

Q3 2026

Indexed institutions

71

Top holders

10

Ownership snapshot

Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
11/15
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 4 rows are not safely comparable across share classes. 13D/G row: Vivo Opportunity Fund Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.

11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership Top 5
Vivo Opportunity Fund Holdings, L.P. 10%
RA CAPITAL MANAGEMENT, L.P. 9.9%
Commodore Capital LP 9.9%
BIOTECHNOLOGY VALUE FUND L P 9.1%
Caligan Partners LP 8.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vivo Opportunity Fund Holdings, L.P.
13D/G
10%
Reported 13D/G · 30 Sep 2026
$70,651,378
22,287,501 shares
-$1,108,254 30 Sep 2026
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
9.9%
Reported 13D/G · 06 Aug 2026
$38,055,014
9,609,852 shares
+$9,102,563 06 Aug 2026
Commodore Capital LP
13D/G 13F
Company
9.9%
Reported 13D/G · 30 Jun 2026
$35,434,753
8,948,170 shares
+$17,523,764 30 Jun 2026
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
9.1%
Reported 13D/G · 31 Dec 2025
$18,761,910
4,761,906 shares
-$1,598,505 31 Dec 2025
Caligan Partners LP
13D/G 13F
Company
8.8%
Reported 13D/G · 30 Jun 2026
$31,550,140
7,967,207 shares
$0 30 Jun 2026
Adage Capital Management, L.P.
13D/G
8.4%
Reported 13D/G · 30 Jun 2026
$25,365,990
6,405,553 shares
$0 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
71
Shares
69,718,713
Indexed holders
71
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 indexed holders
88
Q3 2026 indexed holders
71
Indexed holder difference
-17
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .